Hem › Multipelt myelom › New Hampshire
Kliniska studier för Multipelt myelom i New Hampshire
4 studier för Multipelt myelom söker deltagare vid platser i New Hampshire.
Officiell studietext (engelska)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Dartmouth Hitchcock Medical Center, Lebanon
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NH Oncology - Hematology, PA, Concord
- Solinsky Center for Cancer Care, Manchester
- New England Cancer Specialist, Portsmouth
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT02693535A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- Dartmouth-Hitchcock Medical Center, Lebanon
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT07280013Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Exeter Hospital, Exeter
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 10 juni 2026 · NCT05561387Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.